216 related articles for article (PubMed ID: 7510835)
1. An in situ protocol for measuring the expression of chemically-induced mutations in mammalian cells.
Spencer DL; Hines KC; Caspary WJ
Mutat Res; 1994 Apr; 312(2):85-97. PubMed ID: 7510835
[TBL] [Abstract][Full Text] [Related]
2. In situ and suspension protocols for chemically-induced mutation at the tk locus in L5178Y MOLY cells: dose response and colony size distribution.
Spencer DL; Caspary WJ
Mutat Res; 1994 Oct; 322(4):291-300. PubMed ID: 7523923
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous mutation rates in mammalian cells: effect of differential growth rates and phenotypic lag.
Rudd CJ; Daston DS; Caspary WJ
Genetics; 1990 Oct; 126(2):435-42. PubMed ID: 2123164
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the soft agar and microtitre methodologies for the L5178Y tk +/- mouse lymphoma assay.
Oberly TJ; Yount DL; Garriott ML
Mutat Res; 1997 Jan; 388(1):59-66. PubMed ID: 9025792
[TBL] [Abstract][Full Text] [Related]
5. Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells.
Moore MM; Clive D; Hozier JC; Howard BE; Batson AG; Turner NT; Sawyer J
Mutat Res; 1985 Aug; 151(1):161-74. PubMed ID: 3927157
[TBL] [Abstract][Full Text] [Related]
6. Chromosome analysis of small and large L5178Y mouse lymphoma cell colonies: comparison of trifluorothymidine-resistant and unselected cell colonies from mutagen-treated and control cultures.
Blazak WF; Los FJ; Rudd CJ; Caspary WJ
Mutat Res; 1989 Oct; 224(2):197-208. PubMed ID: 2507912
[TBL] [Abstract][Full Text] [Related]
7. The mouse lymphoma assay.
Lloyd M; Kidd D
Methods Mol Biol; 2012; 817():35-54. PubMed ID: 22147567
[TBL] [Abstract][Full Text] [Related]
8. In situ analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells.
Moore MM; Clive D; Howard BE; Batson AG; Turner NT
Mutat Res; 1985 Aug; 151(1):147-59. PubMed ID: 3927156
[TBL] [Abstract][Full Text] [Related]
9. Do trifluorothymidine-resistant mutants of L5178Y mouse lymphoma cells re-express thymidine kinase activity following 5-azacytidine treatment?
Moore MM; Applegate ML; Hozier JC
Mutat Res; 1988 Feb; 207(2):77-82. PubMed ID: 2448615
[TBL] [Abstract][Full Text] [Related]
10. The use of L5178Y mouse lymphoma cells to assess the mutagenic, clastogenic and aneugenic properties of chemicals.
Combes RD; Stopper H; Caspary WJ
Mutagenesis; 1995 Sep; 10(5):403-8. PubMed ID: 8544753
[TBL] [Abstract][Full Text] [Related]
11. The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells.
Moore-Brown MM; Clive D; Howard BE; Batson AG; Johnson KO
Mutat Res; 1981 Oct; 85(5):363-78. PubMed ID: 6795499
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of mutations at the tk locus of L5178Y mouse-lymphoma cells induced by ethyl methanesulphonate and mitomycin C.
Davies MJ; Phillips BJ; Rumsby PC
Mutat Res; 1993 Dec; 290(2):145-53. PubMed ID: 7694105
[TBL] [Abstract][Full Text] [Related]
13. Thymidine kinase activity and trifluorothymidine resistance of spontaneous and mutagen-induced L5178Y cells in RPMI 1640 medium.
Oberly TJ; Bewsey BJ; Probst GS
Mutat Res; 1986 Jul; 161(2):165-71. PubMed ID: 3088439
[TBL] [Abstract][Full Text] [Related]
14. Stability of tk-/- mutants of L5178Y mouse lymphoma cells in Fischer's medium.
Clive D; Krehl R
Mutat Res; 1991 Aug; 260(4):409-13. PubMed ID: 1908056
[TBL] [Abstract][Full Text] [Related]
15. Trifluorothymidine resistance and colony size in L5178Y/TK +/- cells treated with methyl methanesulfonate.
Amacher DE; Paillet SC
J Cell Physiol; 1981 Mar; 106(3):349-60. PubMed ID: 6783669
[TBL] [Abstract][Full Text] [Related]
16. TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidine.
McGregor DB; Brown AG; Cattanach P; Shepherd W; Riach C; Daston DS; Caspary WJ
Carcinogenesis; 1989 Nov; 10(11):2003-8. PubMed ID: 2478309
[TBL] [Abstract][Full Text] [Related]
17. Studies on the activities of benzo[a]pyrene, benzidine and ethyl methanesulphonate in the L5178Y TK +/- mouse lymphoma mutagenicity assay using standardized and non-standardized protocols.
Riach CG; Cattanach PJ; Howgate S; Shepherd W; McBride D; Edwards IW; McGregor DB; Combes RD
Mutagenesis; 1990; 5 Suppl():35-44. PubMed ID: 2184319
[TBL] [Abstract][Full Text] [Related]
18. Mutant frequencies and loss of heterozygosity induced by N-ethyl-N-nitrosourea in the thymidine kinase gene of L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
Chen T; Harrington-Brock K; Moore MM
Mutagenesis; 2002 Mar; 17(2):105-9. PubMed ID: 11880538
[TBL] [Abstract][Full Text] [Related]
19. Mutagenesis at the ouabain-resistance locus of 3.7.2C L5178Y cells by chromosomal mutagens.
Amacher DE; Dunn EM
Environ Mutagen; 1985; 7(4):523-33. PubMed ID: 2996875
[TBL] [Abstract][Full Text] [Related]
20. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. II: 18 coded chemicals.
McGregor DB; Brown A; Cattanach P; Edwards I; McBride D; Caspary WJ
Environ Mol Mutagen; 1988; 11(1):91-118. PubMed ID: 3338442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
